Back to Search
Start Over
Comments on the three papers by the FDA/CDER research team on the regulatory perspective of the missing data problem.
- Source :
-
Statistics in Medicine . 7/30/2016, Vol. 35 Issue 17, p2880-2886. 7p. - Publication Year :
- 2016
-
Abstract
- This communication comments on the three papers by the FDA CDER research team on the regulatory perspective of the missing data problem. The focus is on two topics: causal estimand and sensitivity analysis. Copyright © 2016 John Wiley & Sons, Ltd. [ABSTRACT FROM AUTHOR]
- Subjects :
- *EXPERIMENTAL design
*RESEARCH
*STATISTICS
*DATA analysis
Subjects
Details
- Language :
- English
- ISSN :
- 02776715
- Volume :
- 35
- Issue :
- 17
- Database :
- Academic Search Index
- Journal :
- Statistics in Medicine
- Publication Type :
- Academic Journal
- Accession number :
- 116617864
- Full Text :
- https://doi.org/10.1002/sim.6895